Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 구세영 | - |
dc.date.accessioned | 2024-04-18T05:14:57Z | - |
dc.date.available | 2024-04-18T05:14:57Z | - |
dc.date.issued | 2023-03-10 | - |
dc.identifier.citation | Med | en_US |
dc.identifier.issn | 2666-6359 | en_US |
dc.identifier.uri | https://information.hanyang.ac.kr/#/eds/detail?an=36549297&dbId=cmedm | en_US |
dc.identifier.uri | https://repository.hanyang.ac.kr/handle/20.500.11754/189872 | - |
dc.description.abstract | With the integration of nanotechnology into the medical field at large, great strides have been made in the development of nanomedicines for tackling different diseases, including cancers. To date, various cancer nanomedicines have demonstrated success in preclinical studies, improving therapeutic outcomes, prolonging survival, and/or decreasing side effects. However, the translation from bench to bedside remains challenging. While a number of nanomedicines have entered clinical trials, only a few have been approved for clinical applications. In this review, we highlight the most recent progress in cancer nanomedicine, discuss current clinical advances and challenges for the translation of cancer nanomedicines, and provide our viewpoints on accelerating clinical translation. We expect this review to benefit the future development of cancer nanotherapeutics specifically from the clinical perspective. | en_US |
dc.description.sponsorship | The authors acknowledge the support from the National Natural Science Foundation, China (32101209 to Z.P.), Guangzhou Basic and Applied Basic Research Foundation, China (202201011237 to Z.P.), Natural Science Foundation of Anhui Province (2008085QH383 to Z.P.), a Harvard Medical School/Brigham and Women’s Hospital Department of Anesthesiology-Basic Scientist Grant, United States (no. 2420 BPA075 to W.T.), Nanotechnology Foundation, United States (no. 2022A002721 to W.T.), a Gillian Reny Stepping Strong Center for Trauma Innovation Breakthrough Innovator Award, United States (no. 113548 to W.T.), and Center for Nanomedicine Research Fund, United States (no. 2019A014810 to W.T.). W.T. is also a recipient of the Khoury Innovation Award, United States (no. 2020A003219) and the American Heart Association (AHA) Collaborative Science Award, United States (no. 2018A004190). | en_US |
dc.language | en_US | en_US |
dc.publisher | Cell Press | en_US |
dc.relation.ispartofseries | Vol. 4 (3);147-167 | - |
dc.subject | cancer nanomedicine | en_US |
dc.subject | clinical translation | en_US |
dc.subject | current status | en_US |
dc.subject | future prospects | en_US |
dc.subject | Forecasting | en_US |
dc.subject | Humans | en_US |
dc.subject | Nanomedicine | en_US |
dc.subject | Nanoparticles | en_US |
dc.subject | Nanotechnology | en_US |
dc.subject | Neoplasms | en_US |
dc.title | Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1016/j.medj.2022.12.001 | en_US |
dc.relation.journal | Med | - |
dc.contributor.googleauthor | Zhang, Pengfei | - |
dc.contributor.googleauthor | Xiao, Yufen | - |
dc.contributor.googleauthor | Sun, Xue | - |
dc.contributor.googleauthor | Lin, Xiaoning | - |
dc.contributor.googleauthor | Koo, Seyoung | - |
dc.contributor.googleauthor | Yaremenko, Alexey V. | - |
dc.contributor.googleauthor | Qin, Duotian | - |
dc.contributor.googleauthor | Kong, Na | - |
dc.contributor.googleauthor | Farokhzad, Omid C. | - |
dc.contributor.googleauthor | Tao, Wei | - |
dc.relation.code | 2023018814 | - |
dc.sector.campus | E | - |
dc.sector.daehak | COLLEGE OF SCIENCE AND CONVERGENCE TECHNOLOGY[E] | - |
dc.sector.department | DEPARTMENT OF CHEMICAL AND MOLECULAR ENGINEERING | - |
dc.identifier.pid | sykoo | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.